Примери за използване на Union authorisation на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Union authorisation- ECHA.
Evaluation process for union authorisation- ECHA.
Union authorisation process has the following steps.
Dossier submission for union authorisation- ECHA.
In the case of a Union authorisation the notification must be sent to ECHA and the Commission.
That report shall contain an assessment of the exclusion of product-types 14, 15, 17, 20 and 21 from the Union authorisation.
Deadlines for Union authorisation applications.
Union authorisation gives all Member States the same rights and obligations than those received by national authorisations. .
The list of biocidal products with Union authorisation will be published on the ECHA website.
However, the BPR also provides applicants with the possibility of a new type of authorisation at Union level(Union authorisation).
In case of the change of a Union authorisation, the notification or application must be sumitted to ECHA.
The Member States will be responsible for evaluating the applications for approval of active substances or Union authorisation of biocidal products.
Union authorisation will give the same rights and obligations in all the Members States as those provided by national authorisations. .
The agency's tasks include, among others, delivering opinions on the approval of active substances and the Union authorisation of biocidal products.
For products containing existing active substances, Union authorisation can be granted in three stages, depending on the product-type.
Together with the EU Member States, the Commission will take the final decision on the approval of the active substances and on the Union authorisation of biocidal products.
A Union authorisation issued by the Commission in accordance with this Section shall be valid throughout the Union unless otherwise specified.
Commission Implementing Regulation(EU) 2019/1844 of 22 October 2019 granting a Union authorisation for the biocidal product family‘BPF_Iodine_VET'( 1).
Furthermore, it is possible to apply for national authorisation starting from a(prospective)reference product having(or seeking to have) a Union authorisation.
Once the evaluating competent authority has validated the application for the Union authorisation of a biocidal product(or a biocidal product family), the evaluation process starts.
You cannot apply for Union authorisation if the product contains active substances meeting the exclusion criteria or belongs to product types 14, 15, 17, 20 or 21.
A product containing new active substances, also in combination with existing active substances,is eligible for Union authorisation from 1 September 2013.
For biocidal products containing only existing active substances, Union authorisation will be available in three different stages, depending on the product-type.
(e) applications for Union authorisation of biocidal products and for renewal, cancellation and amendments of Union authorisations, except where the applications are for administrative changes;
Commission Implementing Regulation(EU)2019/1794 of 22 October 2019 granting a Union authorisation for the biocidal product family‘Boumatic Iodine product family'.
The Union authorisation is an administrative act used by the European Commission to permit accessibility to the market and the use of the biocidal product or family of biocidal products on the Union territory or part of its territory.
The Biocidal Products Committee gives a scientific opinion on active substances(approval, renewal, review,inclusion in Annex I), Union authorisation of biocidal products and mutual recognition.
The table below lists the deadlines for Union authorisation applications, which are necessary to keep existing products on the market.
Union authorisation will be granted to biocidal products with similar conditions of use across the Union, except those containing active substances meeting the exclusion criteria and certain product-types(14, 15, 17, 20 and 21).
Member States may restrict or prohibit the cultivation of GMOs in all orpart of their territory as from the date of entry into force of the Union authorisation and for the whole duration of the consent/authorisation, provided that an established standstill period, during which the Commission was given the opportunity to comment on the proposed measures, has elapsed.